Home › Research › Health systems and care delivery
Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia
Elizabeth M. White, Pedro L. Gozalo, Christopher M. Santostefano, Cyrus M. Kosar, Brian E. McGarry, Fangli Geng, Robert A. Zorowitz, David C. Grabowski et al.. JAMA Health Forum, 2026-05-31
Topic: Risk, prevention and care in population studies
The study cohort included 1 415 265 long-stay nursing home residents with dementia who died between 2013 and 2022. The unadjusted hospitalization rate in the last 30 days of life was 27.7%. UHC I-SNP enrollment was associated with a 9.0-percentage point (pp) reduction in hospitalization (95% CI, -10.3 pp to -7.7 pp) while non-UHC I-SNP enrollment was associated with a 5.9-pp reduction (95% CI, -8.4 pp to -3.5 pp). The spillover effect on nonenrollees in nursing homes offering a UHC I-SNP was a 1.7-pp (95% CI, -2.4 pp to -1.1 pp) decline in hospitalizations; the spillover effect in non-UHC nursing homes was not statistically significant. Similar trends appeared with hospitalization in the last 3 days of life, intensive care unit admission, and mechanical ventilation, but there was no association with hospice use. The reduction in hospitalizations increased in the 3 years after nursing home I-SNP adoption, then plateaued. Conclusions and Relevance: In this retrospective cohort study, I-SNP enrollment was associated with significantly fewer hospitalizations for nursing home residents with dementia at the end of life, with effect sizes larger for UHC vs non-UHC I-SNPs. Plan maturity and volume are likely important factors impacting success.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
White, E. M., Gozalo, P. L., Santostefano, C. M., Kosar, C. M., McGarry, B. E., Geng, F., et al. (2026). Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2026.1649
Vancouver
White EM, Gozalo PL, Santostefano CM, Kosar CM, McGarry BE, Geng F, et al. Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia. JAMA Health Forum. 2026. doi:10.1001/jamahealthforum.2026.1649. PMID: 42218737.
BibTeX
@article{white2026-42218737,
author = {White, Elizabeth M. and Gozalo, Pedro L. and Santostefano, Christopher M. and Kosar, Cyrus M. and McGarry, Brian E. and Geng, Fangli and Zorowitz, Robert A. and Grabowski, David C. and others},
title = {{Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia}},
journal = {JAMA Health Forum},
year = {2026},
doi = {10.1001/jamahealthforum.2026.1649},
pmid = {42218737},
url = {https://doi.org/10.1001/jamahealthforum.2026.1649}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The study cohort included 1 415 265 long-stay nursing home residents with dementia who died between 2013 and 2022.
- The unadjusted hospitalization rate in the last 30 days of life was 27.7%.
- UHC I-SNP enrollment was associated with a 9.0-percentage point (pp) reduction in hospitalization (95% CI, -10.3 pp to -7.7 pp) while non-UHC I-SNP enrollment was associated with a 5.9-pp reduction (95% CI, -8.4 pp to -3.5 pp).
- The spillover effect on nonenrollees in nursing homes offering a UHC I-SNP was a 1.7-pp (95% CI, -2.4 pp to -1.1 pp) decline in hospitalizations; the spillover effect in non-UHC nursing homes was not statistically significant.
- Similar trends appeared with hospitalization in the last 3 days of life, intensive care unit admission, and mechanical ventilation, but there was no association with hospice use.
Why it matters
This study found that nursing home residents with dementia who were enrolled in certain Medicare Advantage special needs plans were less likely to be hospitalized near the end of life. It is about end-of-life care and hospital use, not about treating, curing, or preventing Alzheimer's disease itself.
Study details
- Study designcohort study
- Effect size27.7%
- Evidence strengthModerate
How this study scored 50/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (JAMA Health Forum) |
| Journal's citation record | 0 / 4 | JAMA Health Forum: journal h-index 60 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 8.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Momotazur Rahman: h-index 35 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42218737) |
| Free to read | 2 / 2 | Free to read |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamahealthforum.2026.1649
- PubMed: 42218737
- Original source →
- Free full text: JAMA Health Forum →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery
Also tagged “care”
995 studies in the library carry the topic tag “care”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.